Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
2022

Share:

Dare to Achieve Genome & Company

Corporate identity

Genome & Company is a clinical-stage biotechnology company based in Korea. Their research and development program focuses on microbiome-based products. However, they have also invested in the immuno-oncology microbiome and positioned themselves to ensure people's right to health, creating possibilities for treatment beyond existing medical treatments. The company strives to create a world where microbiomes can be more accessible to even ordinary people. The design renders a microbiome world in an artistic manner through the use of hand-made brushstrokes that convey the organic quality of the products. The goal is to position Genome & Company as more than just another scientific biotechnology company but rather a friendly entity.

Client / Manufacturer

Genome & Company

Gyeonggi-do, KR
Designer
Interbrand Seoul

Interbrand Seoul

Seoul, KR

Genome & Company

Gyeonggi-do, KR
Date of Launch
2021
Development Time
up to 12 months
Target Regions
Specific country/region: Research centers and tertiary hospitals in South Korea and pharmaceutical companies globally.
Target Groups
Other target groups: Immuno-onclogy focused Research & Development, Pharmaceuticals, Cosmeceuticals, Dietary Supplements

RELATED PROJECTS